Cholestatic hepatitis during treatment with mexiletine/lidocaine
Geisler, C.; Keiding, S.
Ugeskrift for Laeger 146(16): 1212-1213
1984
ISSN/ISBN: 0041-5782 PMID: 6730049 Document Number: 230312
Document emailed within 1 workday
Related Documents
Beltrame, J.; Aylward, P.E.; McRitchie, R.J.; Chalmers, J.P. 1984: Comparative haemodynamic effects of lidocaine, mexiletine, and disopyramide Journal of Cardiovascular Pharmacology 6(3): 483-490Rolli, A.; Bonatti, V.; Finardi, A.; Favaro, L.; Botti, G. 1981: Comparative study of the anti-arrhythmic activity of mexiletine and lidocaine in ventricular hyperkinetic arrhythmias Giornale Italiano di Cardiologia 11(4): 468-476
Tăpălagă, D.; Fodor, O.; Nicoară, A. 1978: Treatment of cholestatic hepatitis with phenobarbital Medecine Interne 16(2): 169-174
Kowalski, R.; Dropiński, J.; Brzostek, T.; Szot, Pł.; Rzeszutko, M.; Kasper, M.; Sawicka, A.; Szczeklik, A. 2008: Cholestatic hepatitis as a ticlopidine-induced complication of treatment - a case report Kardiologia Polska 66(7): 758-760
Fritz, K.W.; Riethmüller, H.; Hempelmann, G. 1981: Comparative haemodynamic studies with mexiletine and lidocaine in patients with coronary heart disease after aorto-coronary bypass Der Anaesthesist 30(11): 567-568
Kaneko, J.; Sugawara, Y.; Akamatsu, N.; Kokudo, N.; Makuuchi, M. 2004: Cholestatic hepatitis due to hepatitis C virus after a living donor liver transplantation Hepato-Gastroenterology 51(55): 243-244
Poupon, R.Y.; Meyniel, D.; Petit, J.; Gustot, P.; Darnis, F. 1979: Cholestatic hepatitis during treatment with I.N.H. and rifampicin: arguments in favour of the hepatotoxicity of rifampicin Annales de Medecine Interne 130(6-7): 371-375
Nielsen, O.H.; Kvist, N. 1982: Biliary atresia and neonatal hepatitis. Differential diagnosis and therapeutic possibilities in neonatal cholestatic hepatitis Ugeskrift for Laeger 144(22): 1589-1593
Bruguera, M. 1997: Cholestatic hepatitis associated with ticlopidine Gastroenterologia y Hepatologia 20(3): 163-164
Cofré, C.; Valdés, E.; Tapia, A.; Rodríguez, J. 1986: Cholestatic hepatitis secondary to propylthiouracil Revista Medica de Chile 114(1): 42-44
Bensaude, R.J.; Furet, Y.; Autret, E.; Brottes, H.; Billard, J.L.; Breteau, M. 1988: Cholestatic hepatitis caused by ketoconazole Annales de Gastroenterologie et d'Hepatologie 24(2): 55-57
Cales, P.; Voigt, J.J.; Suduca, J.M.; Bord, E.; Vinel, J.P.; Pascal, J.P. 1987: Cholestatic hepatitis caused by carbimazole Presse Medicale 16(20): 1005
Bories, P.; Pomier-Layrargues, G.; Chotard, J.P.; Citron, D.; Capron-Chivrac, D.; Capron, J.P.; Michel, H. 1980: Amineptine-induced cholestatic hepatitis. 5 cases La Nouvelle Presse Medicale 9(48): 3689-3692
Pierson, H.; Preiss, M.A.; Penin, F.; Cuny, G. 1987: Cholestatic hepatitis in a patient taking levomepromazine Annales de Gastroenterologie et d'Hepatologie 23(2): 101
Fuchs, M.; Pfeiffer, A.; Kaess, H. 1996: 52-year-old patient with a cholestatic form of hepatitis Der Internist 37(7): 735-738
Calvo Rigual, F.; Hernández Aguilar, M.T.; Hervás Andrés, A. 1991: Cholestatic viral hepatitis A. Apropos of a case Anales Espanoles de Pediatria 34(3): 235-236
Poniachik, J.; Guerrero, J.; Calderón, P.; Smok, G.; Morales, A.; Muñoz, G.; Venegas, M. 1998: Cholestatic hepatitis associated with piroxicam use. Case report Revista Medica de Chile 126(5): 548-552
Ferrer, A.; Buenestado, J.; Reñé, J.M.; Piñol, M.C. 1994: Acute cholestatic hepatitis caused by droxicam Atencion Primaria 14(1): 583
Tunuguntla, A.; Patel, M.; Hudgins, L.B. 2005: Gatifloxacin-induced cholestatic hepatitis--a challenging diagnosis Tennessee Medicine: Journal of the Tennessee Medical Association 98(3): 133-134
Devars du Mayne, J.F.; Bouchacourt, E.; Hardouin, J.P. 1980: Acute pancreatitis cholestatic hepatitis induced by estroprogestatives La Nouvelle Presse Medicale 9(46): 3550-3551